Are you a big enough fan to have spotted the secret Star Wars tribute hidden across all of Marvel Phase Two? We break down ...

WILMINGTON, N.C., July 07, 2026 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ: NCNO), the platform for agentic AI banking, today announced that San ...

You don’t really feel your hamstrings and glutes firing. If you’ve spent time on FitTok or in workout classes, you may have heard that this is the ideal experience to have when performing an exercise.

Envirotech Vehicles, Inc. (NASDAQ: EVTV) (“EVTV” or the “Company”) today announced the successful completion of its merger ...

Maria Mancinas has waited more than 30 years to see a 25-acre vacant lot along University and Mesa drives called Site 17 be ...

We asked the experts.

A new trail connection at Seven Bends State Park is giving hikers, runners and cyclists easier access to one of the ...

The upcoming X-Men reboot may not be the only Marvel Studios film expected to focus on mutant characters. A new report has suggested that another major sequel slated for the franchise’s next phase ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of ...

Who'll Own Your Inevitable AI Assistant? The Battle Is On, and I Predict One Winner ...

EMERGE is a global, randomized, multicenter, placebo-controlled Phase 3 trial that will evaluate claseprubart 300mg/2mL S.C. dosed Q2W and Q4W vs. placebo, with top-line results anticipated in 2H’28 ...

CNW/ - Takeda Canada Inc. ("Takeda") is pleased to announce positive topline results for the Phase 3, randomized, multicenter ...